A comparative cost analysis of digital fundus imaging and direct fundus examination for assessment of diabetic retinopathy

Telemedicine and e-Health

Volumn 14, Issue 9, 2008, Pages 912-918

  Gomez Ulla, Francisco ^a,b   Alonso, Florentina ^a   Aibar, Beatriz ^c   Gonzalez, Francisco ^a,d  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Instituto Tecnologico de Oftalmologia   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cost analysis; Diabetic retinopathy; Digital fundus imaging; Direct fundus examination

Indexed keywords

COST ACCOUNTING; COSTS; DIGITAL ARITHMETIC; EYE PROTECTION; IMAGE ENHANCEMENT; PERSONNEL; SUGAR (SUCROSE);

ADDITIONAL COSTS; CAPITAL COSTS; CONSUMABLES; COST ANALYSES; COST ANALYSIS; DIABETIC RETINOPATHIES; DIABETIC RETINOPATHY; DIGITAL FUNDUS IMAGES; DIGITAL FUNDUS IMAGING; DIGITAL IMAGES; DIRECT FUNDUS EXAMINATION; FUNDUS CAMERAS; FUNDUS IMAGING; HEALTHCARE SYSTEMS; TIME LOSSES; TRAVEL COSTS; TRAVEL EXPENSES;

COST BENEFIT ANALYSIS;

ARTICLE; COMPARATIVE STUDY; CONSULTATION; COST BENEFIT ANALYSIS; DIABETIC RETINOPATHY; DIGITAL IMAGING; EYE FUNDUS; HEALTH CARE COST; HUMAN; MEDICAL SPECIALIST; PRIORITY JOURNAL;

COSTS AND COST ANALYSIS; DIABETIC RETINOPATHY; FUNDUS OCULI; HUMANS; REMOTE CONSULTATION; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 57049181406     PISSN: 15305627     EISSN: 15563669     Source Type: Journal    
DOI: 10.1089/tmj.2008.0013     Document Type: Article

References (40)

1. Harris M, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population ages 20-74 years. Diabetes 1987;36:534-534.
2. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. ETDRS report number 1. Arch Ophthalmol 1985;103:1796-1806.
3. Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991;98:766-785.
4. Ferris FL. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1291.
5. Javitt JC, Aiello LP, Chiang Y, Ferris FL, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government: Implications for health-care reform. Diabetes Care 1994;17:909-917.
6. Kraft SK, Marrero DG, Lazaridis EN, Fineberg N, Qiu C, Clark CM. Primary care physicians' practice patterns and diabetic retinopathy: Current levels of care. Arch Fam Med 1997;6:29-37.
7. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, Palta M. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XIX. Arch Ophthalmol 2004;122:76-83.
8. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Kleir R. Diabetic retinopathy. Diabetes Care 2003;26:226-229.
9. Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993;270:1714-1718.
10. Schoenfeld ER, Greene JM, Wu SY, Leske C. Patterns of adherence to diabetes vision care guidelines: Baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 2001;108:563-571.
11. Zimmer-Galler IE. Teleophthalmology assessment of diabetic retinopathy. In: Yogesan K, Kumar S, Goldschmidt L, Cuadros J, eds. Teleophthalmology. New York: Springer, 2006:79-85.
12. Gómez-Ulla F, Fernández MI, Gonzalez F, Rey P, Rodríguez M, Rodríguez-Cid MJ, Casanueva FF, Tome MA, García-Tobio J, Gude F. Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy. Diabetes Care 2002;25:1384-1389.
13. Gonzalez F, Iglesias R, Gómez-Ulla F, Fernández MI. Telemedicine reduces referral of diabetic patients to ophthalmologists. J Telemed Telecare 2003;9:307-308.
14. Abreu Reyes P, Gil Hernández MA, Abreu R. Telemedicine screening of diabetic retinopathy: Our experience. Arch Soc Canar Oftalmol 2003;14:21-24.
15. Baeza Díaz M, Gil Guillén V, Orozco Beltrán D, Pedrera Carbonell V, Ribera Montes C, Pérez Pons I, Martínez- Toldos J. Validity of the nonmydriatic camera for diabetic retinopathy screening and analysis of retinopathy risk indicators. Arch Soc Esp Oftalmol 2004;79:433-441.
16. Cabasés Hita JM. Analisis Coste-Beneficio. Health Services of the Andalucian Community Council, Andalucia, Spain, Technical Documents, April 1994;7:1-45. [in Spanish].
17. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for economical evaluation of health services programs. 2nd ed. Madrid: Diaz de Santos, SA, 2001. [in Spanish].
18. Blanco Dopico MI, Aibar Guzman B, Rios Blanco SL. Contabilidad de Costes: Cuestiones, supuestos prácticos resueltos y propuestos. Madrid: Prentice Hall, 2001.
19. Wallace P, Haines A, Harrison R, Barber J, Thompson S. Joint teleconsultations (virtual outreach) versus standard outpatients appointments for patients referred by their general practitioner for a specialist opinion: A randomised trial. Lancet 2002;359:1961-1968.
20. Gonzalez F, Iglesias R, Suarez A, Gomez-Ulla F, Perez R. Teleophthalmology link between a primary health care center and a reference hospital. Med Inform Internet Med 2001;26:251-263.
21. Eikelboom RH, Yogesan K, Barry CJ, Constable IJ, Tay-Kearney ML, Jitskaia J, House P. Methods and limits of digital image compression of retinal images for telemedicine. Invest Ophthalmol Vis Sci 2000;41:1916-1924.
22. DOG (Diario Oficial de Galicia). Decree 222/2003. Xunta de Galicia, Spain. 2003;76:4942-4957.
23. DOG (Diario Oficial de Galicia). Decree 83/2004. Xunta de Galicia, Spain. 2004;85:6235-6250.
24. Lopez Bastida J, Cabrera Lopez FA, Abreu Reyes P, Sassi F. Cost-effectiveness analysis of several strategies for screening and treatment of diabetic retinopathy. Institute of Health Carlos III, Spanish Ministry of Health, Report 00/10116, 2001. [in Spanish].
25. Cabrera Lopez F, Cardona Guerra P, Lopez Bastida J, Diaz Arriaga J. Evaluation of effectiveness and cost-effectiveness of digital images for the diagnosis of diabetic retinopathy. Arch Soc Canar 2004;15:21-23. [in Spanish].
26. Hibbar JH, Peters E. Supporting informed consumer health care decisions: Data presentation approaches that facilitate the use of information in choice. Ann Rev Public Health 2003;24:413-433.
27. O'Brien BJ, Drummond MF, Labelle RJ, Willan A. In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:150-627.
28. O'Brien BJ, Drummond MF. Statistical versus quantitative significance in the socioeconomic evaluation of medicines. Pharmacoeconomics 1994;5:389-398.
29. INE (National Institute of Statistics). Trimonthly Survey of Labor Costs. Ministry of Economy and Finance, Spain, 2004. [in Spanish].
30. Peña D, Romo J. Introduction to social science statistics. Madrid: McGraw-Hill, 1997. [in Spanish].
31. Vouri HV. The control of quality in health services. Concepts and methodology. Barcelona: Masson SA, 1989:1-39. [in Spanish].
32. Wilson C, Horton M, Cavallerano J, Aiello LM. Addition of primary care-based retinal imaging technology to an existing eye care professional referral program increased the rate of surveillance and treatment of diabetic retinopathy. Diabetes Care 2005;28:318-322.
33. Cavallerano JD, Aiello LP, Cavallerano AA, Katalinic P, Hock K, Kirby R, Aiello LM; Joslin Vision Network Clinical Team. Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mild diabetic retinopathy. Am J Ophthalmol 2005;140:667- 673.
34. Goday A, Serrano Rios M. Epidemiology of diabetes mellitus in Spain: Critical review and new perspectives. Med Clin (Barcelona) 1994;102:306-315. [in Spanish].
35. Zimmet PZ, McCarty DJ, De Courten MP. The global epidemiology of non insulin dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications 1997;11:60-68.
36. Romero-Aroca P, Fernandez-Alart J, Baget-Bernaldiz M, Mendez-Marin I, Salvat-Serra M. Epidemiology of diabetic retinopathy in patients type II. Observed changes in a population between years 1993 and 2005, after new diagnosis criteria and higher patient control. Arch Soc Esp Oftalmol 2007;82:209-218. [in Spanish].
37. Klein R, Klein BE, Moss SE. Epidemiology of proliferative retinopathy. Diabetes Care 1992;15:1875-1891.
38. Zimmet PZ. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 1999;42:499-518.
39. Baeza-Diaz M, Pedrera V, Reigadas R, Orozco D, Soler F, Miralles S. Agreement on eye fundus examination between general practitioner and ophthalmologist for diabetic retinopathy screening. Arch Soc Esp Oftalmol 1999;74:465-472. [in Spanish].
40. Deb-Joardar N, Germain N, Thuret G, Manoli P, Garcin AF, Millot L, Gavet Y, Estour B, Gain P. Screening for diabetic retinopathy by ophthalmologists and endocrinologists with pupillary dilation and a nonmydriatic digital camera. Am J Ophthalmol 2005;140:814-821.